KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Omega Healthcare Investors (OHI) Non Operating Income (2016 - 2026)

Omega Healthcare Investors' Non Operating Income history spans 16 years, with the latest figure at $4.1 million for Q1 2026.

  • On a quarterly basis, Non Operating Income fell 68.75% to $4.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $113.3 million, a 294.0% increase, with the full-year FY2025 number at $122.4 million, up 570.63% from a year prior.
  • Non Operating Income hit $4.1 million in Q1 2026 for Omega Healthcare Investors, down from $27.5 million in the prior quarter.
  • Over the last five years, Non Operating Income for OHI hit a ceiling of $183.2 million in Q4 2022 and a floor of -$1.4 million in Q3 2024.
  • Historically, Non Operating Income has averaged $35.4 million across 5 years, with a median of $20.4 million in 2023.
  • Biggest five-year swings in Non Operating Income: soared 54763.77% in 2022 and later tumbled 102.87% in 2024.
  • Tracing OHI's Non Operating Income over 5 years: stood at $183.2 million in 2022, then crashed by 88.88% to $20.4 million in 2023, then plummeted by 95.09% to $1.0 million in 2024, then soared by 2647.25% to $27.5 million in 2025, then plummeted by 85.09% to $4.1 million in 2026.
  • Business Quant data shows Non Operating Income for OHI at $4.1 million in Q1 2026, $27.5 million in Q4 2025, and $45.1 million in Q3 2025.